Clene (CLNN) Director Arjun Desai Receives Option Award

What Happened Arjun Desai, a director of Clene Inc. (CLNN), was granted a derivative award on August 13, 2026: options covering 3,674 shares of common stock. The Form 4 reports the acquisition as $0 (a grant), and a footnote states the options carry an exercise price of $4.19 per share and vest immediately upon grant. The filing was submitted the next day (Aug 14, 2026).

Key Details

• Transaction date: 2026-08-13 (filed 2026-08-14).
• Reported acquisition: 3,674 option shares; reported acquisition price $0.00 (grant).
• Exercise price (footnote): $4.19 per share. Options vest immediately upon grant.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: Grant made under the Clene Inc. Amended 2020 Stock Plan; options vest immediately.
• Timeliness: Filing appears timely (reported the day after the grant).

Context This was an option grant (a derivative award), not a cash purchase or sale. An option gives the holder the right to buy shares in the future at the $4.19 strike price; immediate vesting means Desai can exercise these options right away if he chooses. The grant itself does not indicate a stock purchase or sale and should not be read as an immediate change in market exposure until the options are exercised or sold.